Tough Decisions in Inherited Arrhythmia Conditions-Tough Decisions in Inherited Arrhythmia Conditions

Video Transcription

Video Summary

The session focused on the Heart Rhythm Society's event and included discussions on heart disorders, especially CPVT and long QT syndrome. Dr. Christina Miyake reviewed the 2025 AHA and ACC guidelines for CPVT, emphasizing treatment strategies like beta-blockers, flecainide, and ICDs, depending on symptoms and risks. An audience engagement component was suggested through real-case discussions and response questions.<br /><br />Dr. Joseph Otawa discussed the role of sympathectomy, a surgical removal of sympathetic nerves, which can help manage patients with CPVT despite some risks and complications. The efficacy of this procedure varies, with some patients experiencing relapses. Dr. Shu Sanatani elaborated on management strategies for patients asking about stimulants, video games, and participation in activities like roller coasters. He emphasized data-driven decisions and shared patient anecdotes to illustrate potential risks.<br /><br />Finally, Dr. Kirstie McIntyre presented on decreasing the reliance on beta-blockers for certain low-risk long QT patients, citing successful management without beta-blockers, especially in asymptomatic individuals. Audience questions explored practical management and lifestyle modifications for patients with cardiac conditions. Overall, the session aimed to provide insights into current and evolving practices for managing arrhythmia disorders, stressing individualized patient care.

Keywords

Heart Rhythm Society

CPVT

long QT syndrome

beta-blockers

flecainide

ICDs

sympathectomy

arrhythmia management

individualized patient care

cardiac conditions